Bortezomib improves adoptive T-Cell therapy by sensitizing cancer cells to FasL cytotoxicity

Anil Shanker, Samuel T. Pellom, Duafalia F. Dudimah, Menaka Thounaojam, Rachel L. De Kluyver, Alan D. Brooks, Hideo Yagita, Daniel W. McVicar, William J. Murphy, Dan L. Longo, Thomas J. Sayers

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Bortezomib improves adoptive T-Cell therapy by sensitizing cancer cells to FasL cytotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences